KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Treasury Shares: 2018-2025

Historic Treasury Shares for Aquestive Therapeutics (AQST) over the last 6 years, with Sep 2025 value amounting to $2.9 million.

  • Aquestive Therapeutics' Treasury Shares rose 6.01% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 6.01%. This contributed to the annual value of $2.6 million for FY2024, which is 33.98% up from last year.
  • Aquestive Therapeutics' Treasury Shares amounted to $2.9 million in Q3 2025, which was down 12.10% from $3.3 million recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Treasury Shares high stood at $3.3 million for Q1 2025, and its period low was $8,000 during Q2 2021.
  • For the 3-year period, Aquestive Therapeutics' Treasury Shares averaged around $2.5 million, with its median value being $2.7 million (2024).
  • In the last 5 years, Aquestive Therapeutics' Treasury Shares plummeted by 68.18% in 2021 and then soared by 2,025.00% in 2022.
  • Quarterly analysis of 5 years shows Aquestive Therapeutics' Treasury Shares stood at $8,000 in 2021, then soared by 2,025.00% to $162,000 in 2022, then skyrocketed by 1,102.47% to $1.9 million in 2023, then surged by 33.98% to $2.6 million in 2024, then increased by 6.01% to $2.9 million in 2025.
  • Its Treasury Shares was $2.9 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.3 million in Q1 2025.